Latest Close
$0.69
News
JSPR
Jasper Therapeutics, Inc. News
This news view pulls recent coverage and headlines tied to JSPR.
1y Change
-$3.32 (-82.84%)
Market Cap
$19,261,812.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
buy
Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
GlobeNewswire • Mar 30, 2026
Read articleWhy UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab
Insider Monkey • Mar 29, 2026
Read articleJasper Therapeutics to Present at 46th Annual TD Cowen Healthcare Conference
GlobeNewswire • Feb 24, 2026
Read articleJasper Therapeutics reports updated data from briquilimab studies
TipRanks • Jan 9, 2026
Read articleJasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria
GlobeNewswire • Jan 8, 2026
Read articleJasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth
GlobeNewswire • Jan 7, 2026
Read article